Propranolol and Mesenchymal Stromal Cells Combine to Treat Traumatic Brain Injury.

Abstract

UNLABELLED More than 6.5 million patients are burdened by the physical, cognitive, and psychosocial deficits associated with traumatic brain injury (TBI) in the U.S. Despite extensive efforts to develop neuroprotective therapies for this devastating disorder, there have been no successful outcomes in human clinical trials to date. Retrospective studies have… (More)
DOI: 10.5966/sctm.2015-0065

Topics

6 Figures and Tables

Cite this paper

@article{Kota2016PropranololAM, title={Propranolol and Mesenchymal Stromal Cells Combine to Treat Traumatic Brain Injury.}, author={Daniel J. Kota and Karthik S. Prabhakara and Alexandra J van Brummen and Supinder Singh Bedi and Hasen Xue and Bryan B. DiCarlo and Charles S. Cox and Scott D Olson}, journal={Stem cells translational medicine}, year={2016}, volume={5 1}, pages={33-44} }